Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Rigel Pharmaceutical Inc. buy Subdi

Start price
€1.30
01.04.20 / 50%
Target price
€4.88
24.10.24
Performance (%)
-47.02%
End price
€0.69
13.06.22
Summary
This prediction ended on 13.06.22 with a price of €0.69. Massive losses of -47.02% were the result for the BUY prediction by Subdi. Subdi has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Rigel Pharmaceutical Inc. -4.841% -4.841% -32.729% -72.150%
iShares Core DAX® -0.205% 2.949% 17.330% 18.203%
iShares Nasdaq 100 1.613% 5.877% 37.451% 56.281%
iShares Nikkei 225® -0.740% -1.256% 11.847% 5.531%
iShares S&P 500 0.267% 3.240% 29.308% 46.371%

Comments by Subdi for this prediction

In the thread Rigel Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -47.02%
Target price 1.000
Change
Ends at 04.11.21

Hat sich eigentlich positiv entwickelt, bis zum Corona Crash. Die Geschäfts-Aussichten bleiben auch mit Corona gut, und der Kurs ist um einiges günstiger als zuvor.

https://seekingalpha.com/symbol/RIGL

Prediction Buy
Perf. (%) -47.02%
Target price 2.330
Change
Ends at 04.11.21

Kursziel geändert auf 2,33

Rigel launches fostamatinib trial in patients with COVID-19 pneumonia ...
https://seekingalpha.com/news/3590927-rigel-launches-fostamatinib-trial-in-patients-covidminus-19-pneumonia

@SELLers ,

was habt ihr für Gründe die Aktie zu shorten? Ist das eine  unseriöse Firma?? Die News sind doch positiv, oder???

Prediction Buy
Perf. (%) -47.02%
Target price 4.880
Change
Ends at 04.11.21

Kursziel geändert auf 4,88